AbbVie Accelerates Natural Language Processing

AbbVie is a research-based biopharmaceutical company that serves more than 30 million patients in 175 countries. With its global scale, AbbVie partnered with Intel to optimize processes for its more than 47,000 employees. This whitepaper highlights two use cases that are important to AbbVie's research. The first is Abbelfish Machine Translation, AbbVie's language translation service based on the Transformer NLP model, that leverages second-generation Intel Xeon Scalable processors and the Intel Optimization for TensorFlow with Intel oneAPI Deep Neural Network Library (oneDNN). AbbVie was able to achieve a 1.9x improvement in throughput for Abbelfish language translation using Intel Optimization for TensorFlow 1.15 with oneAPI Deep Neural Network Library when compared to TensorFlow 1.15 without oneDNN.1